Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
Implementation of Low-Burden HF Protocol Reduces Hospital Readmissions
02/21/2023
Jolynn Tumolo
“This preliminary evidence suggests that implementation of the heart failure management protocol has the potential to reduce costs and consequences associated with hospital readmission for SNF patients with heart failure,” researchers wrote.
“This preliminary evidence suggests that implementation of the heart failure management protocol has the potential to reduce costs and consequences associated with hospital readmission for SNF patients with heart failure,” researchers wrote.
“This preliminary evidence...
02/21/2023
Annals of Long-Term Care
News
People with Parkinson Disease Demonstrate Greater Delay Discounting
02/17/2023
Jolynn Tumolo
Researchers studied abnormal delay discounting in patients with Parkinson disease, as well as the potential impact of dopaminergic medications.
Researchers studied abnormal delay discounting in patients with Parkinson disease, as well as the potential impact of dopaminergic medications.
Researchers studied abnormal...
02/17/2023
Annals of Long-Term Care
News
Outpatient Monoclonal Antibody Treatment Prevented Hospitalization in Patients with COVID-19 and Hematologic Malignancy
02/17/2023
Jolynn Tumolo
Some patients with hematologic malignancy who received stem cell transplants avoided hospitalization for COVID-19 after being treated with a monoclonal antibody.
Some patients with hematologic malignancy who received stem cell transplants avoided hospitalization for COVID-19 after being treated with a monoclonal antibody.
Some patients with hematologic...
02/17/2023
First Report Managed Care
News
Screening for Social Needs Outside the Comfort Zone of Community Pharmacists
02/16/2023
Jolynn Tumolo
Data demonstrates that when social needs are addressed, medication adherence rates are improved; however, many pharmacists expressed they lack confidence and comfort screening patients in a recent survey.
Data demonstrates that when social needs are addressed, medication adherence rates are improved; however, many pharmacists expressed they lack confidence and comfort screening patients in a recent survey.
Data demonstrates that when...
02/16/2023
Pharmacy Learning Network
News
Antifungal Tablets Recalled
02/16/2023
Jolynn Tumolo
Multiple lots of delayed-release antifungal tablets are under a Class II recall due to out-of-specification degradation results during routine testing.
Multiple lots of delayed-release antifungal tablets are under a Class II recall due to out-of-specification degradation results during routine testing.
Multiple lots of delayed-release...
02/16/2023
Pharmacy Learning Network
News
Pharmacist-Led Antibiotic Intervention Decreases Hospital Readmissions
02/16/2023
Jolynn Tumolo
“Pharmacist expertise on patient habits, compliance, and self-treatment autonomy is of key importance in the choice of antibiotic therapy,” researchers advised.
“Pharmacist expertise on patient habits, compliance, and self-treatment autonomy is of key importance in the choice of antibiotic therapy,” researchers advised.
“Pharmacist expertise on patient...
02/16/2023
Pharmacy Learning Network
News
Combination Therapy Significantly Improves PFS in Patients With NSCLC With High Tumor Mutational Burden
02/15/2023
Jolynn Tumolo
Chemoradiation and adjuvant monoclonal antibody therapy significantly improved outcomes in patients with locally advanced non-small cell lung cancer with high tumor mutational burden.
Chemoradiation and adjuvant monoclonal antibody therapy significantly improved outcomes in patients with locally advanced non-small cell lung cancer with high tumor mutational burden.
Chemoradiation and adjuvant...
02/15/2023
First Report Managed Care
News
Digital-Based Cardiac Rehab May Be Viable for Patients With Heart Failure
02/15/2023
Jolynn Tumolo
Researchers reviewed outcomes after patients with heart failure underwent cardiac rehabilitation via digital therapeutics or usual care.
Researchers reviewed outcomes after patients with heart failure underwent cardiac rehabilitation via digital therapeutics or usual care.
Researchers reviewed outcomes...
02/15/2023
First Report Managed Care
News
Combination Therapy Demonstrates Clinical, Economic Benefit in Certain Patients With CLL
02/15/2023
Jolynn Tumolo
Researchers studied the outcomes of patients with chronic lymphocytic leukemia who were treated with either ibrutinib or fixed-duration obinutuzumab-chlorambucil.
Researchers studied the outcomes of patients with chronic lymphocytic leukemia who were treated with either ibrutinib or fixed-duration obinutuzumab-chlorambucil.
Researchers studied the outcomes...
02/15/2023
First Report Managed Care
News
Trio of ALS Molecular Subtypes With Varying Patient Survival Identified
02/15/2023
Jolynn Tumolo
A patient stratification analysis identified 3 unique molecular subtypes of amyotrophic lateral sclerosis (ALS), which are associated with differences in patient prognosis.
A patient stratification analysis identified 3 unique molecular subtypes of amyotrophic lateral sclerosis (ALS), which are associated with differences in patient prognosis.
A patient stratification...
02/15/2023
Neurology

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use